Beta Bionics Inc (BBNX)
Beta Bionics stock today
Beta Bionics closed at $16.75 on October 30, 2026, down 4.72% on the day. Over the past year it returned -37.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $754 million.
| Period | BBNX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -11.7% | -0.9% |
| 3 months | +17.4% | +2.1% |
| Year to date | -45.0% | +11.7% |
| 1 year | -37.5% | +12.4% |
Key statistics
- Market value
- $754M
- Price / sales
- 5.9
- 52-week range
- $8.86 to $31.99
About Beta Bionics
Beta Bionics develops medical devices for disease management.
Sector: Health Care
More on Beta Bionics
- Financials: revenue, earnings and segmentsRevenue +54% in the year to Dec 2025
- Returns: what $1,000 became$1,000 one year ago is $625.47 today
No forecast, no recommendation. This page describes Beta Bionics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.